Search for: "SmithKline Beecham" Results 41 - 60 of 437
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2016, 3:36 pm
In these circumstances and absent an error of principle, an appellate court will be very cautious in differing from the judge's evaluation: see SmithKline Beecham's Patent [2006] RPC 323 at [38] per Lord Hoffmann; Halliburton Energy Services Inc v Smith International (North Sea) Ltd and anor [2006] EWCA Civ 1715 at [24] to [25] per Jacob LJ" 3. [read post]
16 Jul 2016, 1:48 pm by Schachtman
Not surprisingly, many of Selikoff’s litigation- and regulatory-driven opinions have not fared well, such as the notions that asbestos causes gastrointestinal cancers and that all asbestos minerals have equal potential and strength to cause mesothelioma. [read post]
14 Jul 2016, 3:30 am by Trudo Lemmens
The study involves a reanalysis of the raw data of a Smithkline Beecham (now GSK)-sponsored published study on the efficacy of paroxetine and imipramine for the treatment of depression in adolescents. [read post]
23 Jun 2016, 8:46 am by Seyfarth Shaw LLP
SmithKline Beecham Corp. when considering the exempt status of pharmaceutical sales representatives, may be of use to employers in challenging other recent DOL regulatory changes. [read post]
20 Jun 2016, 3:50 pm by Seyfarth Shaw LLP
Authored by Jeff Glaser As we’ve discussed on this blog before, the Supreme Court’s decision in Christopher v SmithKline Beecham Corp. had many layers. [read post]
6 Jun 2016, 1:08 pm by Lyle Denniston
The Court’s order sending the case of SmithKline Beecham Corp. v. [read post]
6 May 2016, 5:20 am by John Elwood
SmithKline Beecham Corp. [read post]
5 Apr 2016, 2:12 am by Dennis Crouch
SmithKline Beecham Corp., 791 F.3d 388 (3d Cir. 2015). [2] Supreme Court Docket No. 15-1055. [3] 35 U.S.C. [read post]
3 Mar 2016, 5:19 am
Last week’s “breaking news” post on West Virginia’s statutory restoration of the learned intermediary rule started us thinking about how every state now has pro-learned intermediary precedent. [read post]
5 Feb 2016, 7:55 am by Schachtman
Kathy Batty is a bellwether plaintiff in a multi-district litigation[1] (MDL) against Zimmer, Inc., in which hundreds of plaintiffs claim that Zimmer’s NexGen Flex implants are prone to have their femoral and tibial elements prematurely aseptically loosen (independent of any infection). [read post]
26 Jan 2016, 10:43 am by Seyfarth Shaw LLP
SmithKline Beecham Corp., which would have excluded pharmaceutical sales representatives, and favored a “functional,” “flexible,” and “realistic” rather than “technical” and “formalistic” approach to interpreting the FLSA exemption. [read post]
31 Dec 2015, 5:12 am
The iconic Hunger Games line, “may the odds be ever in your favor” pretty much sums up how we feel about our top ten best decisions of 2015. [read post]
24 Dec 2015, 4:00 am by Administrator
Each Thursday we present a significant excerpt, usually from a recently published book or journal article. [read post]